勘误：吉非替尼对晚期非小细胞肺癌患者的肺部毒性：一项随机对照试验的荟萃分析：勘误。
Erratum: Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials: Erratum.
出版信息
Medicine (Baltimore). 2016 Jul 29;95(30):e156a. doi: 10.1097/01.md.0000490127.42415.6a. eCollection 2016 Jul.
Abstract
[This corrects the article DOI: 10.1097/MD.0000000000003008.].
摘要
[本文更正了文章的数字对象标识符：10.1097/MD.0000000000003008。]
相似文献
1
Erratum: Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials: Erratum.勘误：吉非替尼对晚期非小细胞肺癌患者的肺部毒性：一项随机对照试验的荟萃分析：勘误。
Medicine (Baltimore). 2016 Jul 29;95(30):e156a. doi: 10.1097/01.md.0000490127.42415.6a. eCollection 2016 Jul.
2
Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.吉非替尼对晚期非小细胞肺癌患者的肺部毒性：随机对照试验的荟萃分析
Medicine (Baltimore). 2016 Mar;95(9):e3008. doi: 10.1097/MD.0000000000003008.
3
Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials.吉非替尼对比多西他赛治疗既往治疗的晚期非小细胞肺癌：一项随机对照试验的荟萃分析。
Acta Oncol. 2011 May;50(4):582-8. doi: 10.3109/0284186X.2010.546368. Epub 2010 Dec 30.
4
Erratum: Medicine, Volume 95, Issue 23: Erratum.勘误：《医学》，第95卷，第23期：勘误。
Medicine (Baltimore). 2016 Jul 18;95(28):e0916. doi: 10.1097/01.md.0000489580.04709.16. eCollection 2016 Jul.
5
Erratum: A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer: Erratum.勘误：地加瑞克与促性腺激素释放激素激动剂治疗晚期前列腺癌的随机对照试验的荟萃分析和系统评价：勘误。
Medicine (Baltimore). 2016 Dec 9;95(49):e5671. doi: 10.1097/MD.0000000000005671. eCollection 2016 Dec.
6
Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: a systematic review and meta-analysis of clinical trials.吉非替尼和厄洛替尼治疗晚期非小细胞肺癌的间质性肺病风险：临床试验的系统评价和荟萃分析。
Lung Cancer. 2014 Feb;83(2):231-9. doi: 10.1016/j.lungcan.2013.11.016. Epub 2013 Nov 27.
7
Erratum: Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials: Erratum.勘误：钠-葡萄糖协同转运蛋白2抑制剂联合胰岛素治疗糖尿病患者的安全性和有效性：随机对照试验的系统评价和荟萃分析：勘误。
Medicine (Baltimore). 2017 Jun 30;96(26):e7458. doi: 10.1097/MD.0000000000007458. eCollection 2017 Jun.
8
Gefitinib compared with systemic chemotherapy as first-line treatment for chemotherapy-naive patients with advanced non-small cell lung cancer: a meta-analysis of randomised controlled trials.吉非替尼对比系统化疗作为一线治疗用于化疗初治的晚期非小细胞肺癌患者：一项随机对照试验的荟萃分析。
Clin Oncol (R Coll Radiol). 2012 Aug;24(6):396-401. doi: 10.1016/j.clon.2011.09.013. Epub 2011 Oct 22.
9
Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trials.吉非替尼和厄洛替尼治疗转移性非小细胞肺癌：随机临床试验毒性和疗效的荟萃分析
Oncologist. 2015 Apr;20(4):400-10. doi: 10.1634/theoncologist.2014-0154. Epub 2015 Mar 20.
10
Gefitinib plus Fuzheng Kang'ai Formula () in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial.吉非替尼联合扶正抗癌方治疗表皮生长因子受体突变的晚期非小细胞肺癌患者：一项随机对照试验
Chin J Integr Med. 2018 Oct;24(10):734-740. doi: 10.1007/s11655-017-2819-8. Epub 2017 Aug 9.
本文引用的文献
1
Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.吉非替尼对晚期非小细胞肺癌患者的肺部毒性：随机对照试验的荟萃分析
Medicine (Baltimore). 2016 Mar;95(9):e3008. doi: 10.1097/MD.0000000000003008.
Zotero 插件